Pancreas regeneration
Basic/translational research
Bellvitge Institute for Biomedical Research (IDIBELL)
·Barcelona ·

Our team studies the biology of normal pancreatic tissue as essential knowledge for understanding the cellular and medical “drama” associated with the development of pancreatic cancer. Specifically, we study ductal cells and the role they play in pancreatic regeneration and exocrine pathogenesis, including pancreatic cancer. The main project we have related to PDAC is focused on the cell of origin. We have generated new lineage-tracing mouse lines from previously unknown ductal populations to study the early stages and development of ductal-derived pancreatic tumors and define early biomarkers and novel therapies by using in vivo and organoid models of mouse and human PDAC samples.

Main publications in pancreatic cancer:

  1. PMID: 34330784

Principal Investigator

Group members

Joan Casamitjana (postdoc)

Ángel Fernández (PhD student)

Adrián Holguín (PhD student)

Marina Bermúdez (técnico de laboratorio)

Cecilia Chambers (postdoc, empieza en julio)

Joel Moro (bioinformatician, empieza en julio)

Other groups

Cancer Genetics and Precision Medicine – Zabra Lab

We aim to tackle pancreatic cancer dreadful reality by using in vivo and ex vivo models that faithfully recapitulate the genetic alterations commonly found in patients. In the lab, we have successfully developed and established orthotopic and metastatic syngeneic...

Glycoimmunology Laboratory – Gabriel Rabinovich

The Glycoimmunology Laboratory, led by Dr. Gabriel Rabinovich and currently based at the CaixaResearch Institute (Barcelona), investigates immunoregulatory circuits mediated by lectinin a wide variety of pathological contexts, including cancer, autoimmune diseases,...

Virology and Cellular Immunology Group – Carmen Aguilar

Our group at IrsiCaixa focuses on the development of innovative therapeutic strategies against solid tumors, with a particular emphasis on pancreatic cancer. The group integrates immunological, molecular, and translational approaches to design and evaluate cancer...